Esomeprazole
Esomeprazole
Nexium, Nexium 24HR (OTC)
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Common uses
GERD0, Erosive esophagitis (healing and maintenance)0, H. pylori eradication (combination)0, Zollinger-Ellison syndrome0, NSAID-associated ulcer prophylaxis0
Pharmacy
Starting dose
20-40 mg PO once daily, 30-60 minutes before breakfast
Preparations
20, 40 mg delayed-release capsules; 2.5, 5, 10, 20, 40 mg oral suspension packets; 20, 40 mg IV
US FDA Max
40 mg/d typical; up to 240 mg/d for Zollinger-Ellison
Pharmacology
Routes
Oral, IV
Onset
Acid suppression within hours; full effect after 3-5 days of dosing
Duration
24-72 hours per dose (irreversible enzyme binding)
Half-life
~1.5 hours (plasma); pharmacodynamic effect 24+ hours via target turnover[2]
Bioavailability
~64-90% (oral; increases at higher doses and with multi-day dosing)[2]
Pregnancy
Widely used in obstetric reflux; reassuring data.[citation needed]
Legal status
OTC (20 mg, 14-day course) and Rx-only (higher and longer durations) in US
Purported mechanism
Esomeprazole is the S-enantiomer of omeprazole; chiral separation reduces inter-individual variability driven by CYP2C19-mediated R-enantiomer clearance, yielding more consistent acid suppression than racemic omeprazole, particularly in CYP2C19 extensive metabolizers.0 Like omeprazole, it is an acid-activated prodrug that covalently and irreversibly binds the H+/K+ ATPase. CYP2C19 PGx remains clinically relevant for both[1].
References
- ↑ CPIC Guideline for CYP2C19 and Proton Pump Inhibitors, 2020. https://cpicpgx.org/guidelines/cpic-guideline-for-proton-pump-inhibitors-and-cyp2c19/
- ↑ 2.0 2.1 FDA Prescribing Information, Nexium (esomeprazole magnesium), AstraZeneca, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021153s050,021957s017,022101s014,021689s029,022101s009lbl.pdf